Repro Med Systems/$KRMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Repro Med Systems
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Ticker
$KRMD
Sector
Primary listing
Industry
Health Care Equipment and Supplies
Headquarters
Employees
80
Website
KRMD Metrics
BasicAdvanced
$160M
-
-$0.12
0.39
-
Price and volume
Market cap
$160M
Beta
0.39
52-week high
$5.05
52-week low
$1.86
Average daily volume
337K
Financial strength
Current ratio
2.436
Quick ratio
1.924
Long term debt to equity
18.794
Total debt to equity
22.825
Profitability
EBITDA (TTM)
-4.971
Gross margin (TTM)
63.49%
Net profit margin (TTM)
-15.10%
Operating margin (TTM)
-16.33%
Effective tax rate (TTM)
-0.05%
Revenue per employee (TTM)
$440,000
Management effectiveness
Return on assets (TTM)
-13.09%
Return on equity (TTM)
-29.87%
Valuation
Price to revenue (TTM)
4.524
Price to book
9.77
Price to tangible book (TTM)
10.22
Price to free cash flow (TTM)
-85.067
Free cash flow yield (TTM)
-1.18%
Free cash flow per share (TTM)
-0.041
Growth
Revenue change (TTM)
19.65%
Earnings per share change (TTM)
-60.48%
3-year revenue growth (CAGR)
13.02%
3-year earnings per share growth (CAGR)
-4.04%
What the Analysts think about KRMD
Analyst ratings (Buy, Hold, Sell) for Repro Med Systems stock.
KRMD Financial Performance
Revenues and expenses
KRMD Earnings Performance
Company profitability
KRMD News
AllArticlesVideos
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Business Wire·1 hour ago
KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference
Business Wire·2 days ago
KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Repro Med Systems stock?
Repro Med Systems (KRMD) has a market cap of $160M as of August 01, 2025.
What is the P/E ratio for Repro Med Systems stock?
The price to earnings (P/E) ratio for Repro Med Systems (KRMD) stock is 0 as of August 01, 2025.
Does Repro Med Systems stock pay dividends?
No, Repro Med Systems (KRMD) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Repro Med Systems dividend payment date?
Repro Med Systems (KRMD) stock does not pay dividends to its shareholders.
What is the beta indicator for Repro Med Systems?
Repro Med Systems (KRMD) has a beta rating of 0.39. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.